老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Akari Therapeutics PLC

10.12
-0.1300-1.27%
盤後：10.120.00000.00%19:55 EDT
成交量：1.64萬
成交額：17.16萬
市值：1,970.36萬
市盈率：-0.64
高：11.00
開：11.00
低：9.78
收：10.25
52周最高：49.60
52周最低：3.02
股本：194.70萬
流通股本：69.45萬
量比：0.16
換手率：2.36%
股息：- -
股息率：- -
每股收益(TTM):-15.9015
每股收益(LYR):-20.5537
淨資產收益率：-140.09%
總資產收益率：-19.10%
市淨率：1.06
市盈率(LYR):-0.49

資料載入中...

總覽公司新聞資訊公告
2020/11/16

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/24

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/17

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/07/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/04/15

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/31

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/30

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

SEC問詢函

[Cover]Correspondence
2019/10/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多